Skip to main content

GAIA "Gamma Imaging Applications" platform

The LRB is equipped with a preclinical and clinical nuclear imaging and therapy platform, the GAIA (Gamma Imaging Applications) platform, which includes:
 

  • Two radiochemistry laboratories, where various types of molecules can be labeled with radioactive atoms—gamma emitters (Tc-99m, In-111, …) or positron emitters (Ga-68, F-18, Cu-64) for imaging, as well as beta- (Lu-177, Y-90, Tb-161) and alpha emitters (Ac-225) for therapy.
     
  • Preclinical imaging equipment, including:
    - SPECT (Single Photon Emission Computed Tomography) cameras (nanoSPECT-CT)
    - PET (Positron Emission Tomography) cameras (nanoPET-MRI)
    - Ultrasound system dedicated to small animal imaging.
     
  • A hospital radiopharmacy for labeling molecules transferred to clinical practice.
     
  • Clinical imaging equipment, including SPECT-CT and PET-CT cameras.

     

GAIA is a member of France Life Imaging (FLI) network, was awarded the GIS IBiSA label in 2009 and has a certified quality management system (ISO 9001:2015 / NF X 50-900) since 2020. It is open to scientific collaborations and research contracts with academic and corporate partners.


 Take Your Preclinical and Clinical Studies to the Next Level!

 

gaia_logo_simple.png

 

Our Strengths

- 45 years of expertise
- 14 available radioisotopes
- 2 radiochemistry laboratories
- 6 imaging modalities

Our Areas of Expertise

- Preclinical and clinical nuclear imaging
- Radiolabeling and biodistribution evaluation of novel compounds
- Efficacy assessment of theranostic agents

Submitted on 12 May 2026

Updated on 13 May 2026